Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

Bradley S. Miller; Joanne C. Blair; Michael Højby Rasmussen; Aristides Maniatis; Rasmus Juul Kildemoes; Jun Mori; Michel Polak; Rikke Beck Bang; Volker Böttcher; Stefano Stagi; Reiko Horikawa

doi:10.1210/clinem/dgad095

Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

Bradley S. Miller
, Joanne C. Blair
, Michael Højby Rasmussen
, Aristides Maniatis
, Rasmus Juul Kildemoes
, Jun Mori
, Michel Polak
, Rikke Beck Bang
, Volker Böttcher
, Stefano Stagi
, Reiko Horikawa

Pediatric Endocrinology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e647-e648
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	108
Issue number	8
DOIs	https://doi.org/10.1210/clinem/dgad095
State	Published - Aug 1 2023

Publisher link

10.1210/clinem/dgad095

Find It

Find It at U of M Libraries

Cite this

Miller, B. S., Blair, J. C., Rasmussen, M. H., Maniatis, A., Kildemoes, R. J., Mori, J., Polak, M., Bang, R. B., Böttcher, V., Stagi, S., & Horikawa, R. (2023). Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”. Journal of Clinical Endocrinology and Metabolism, 108(8), e647-e648. https://doi.org/10.1210/clinem/dgad095

Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”. / Miller, Bradley S.; Blair, Joanne C.; Rasmussen, Michael Højby et al.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 108, No. 8, 01.08.2023, p. e647-e648.

Research output: Contribution to journal › Letter › peer-review

Miller, BS, Blair, JC, Rasmussen, MH, Maniatis, A, Kildemoes, RJ, Mori, J, Polak, M, Bang, RB, Böttcher, V, Stagi, S & Horikawa, R 2023, 'Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”', Journal of Clinical Endocrinology and Metabolism, vol. 108, no. 8, pp. e647-e648. https://doi.org/10.1210/clinem/dgad095

@article{cde74f39084c427bb203580b571c3acf,

title = "Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”",

author = "Miller, \{Bradley S.\} and Blair, \{Joanne C.\} and Rasmussen, \{Michael H{\o}jby\} and Aristides Maniatis and Kildemoes, \{Rasmus Juul\} and Jun Mori and Michel Polak and Bang, \{Rikke Beck\} and Volker B{\"o}ttcher and Stefano Stagi and Reiko Horikawa",

year = "2023",

month = aug,

day = "1",

doi = "10.1210/clinem/dgad095",

language = "English (US)",

volume = "108",

pages = "e647--e648",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Endocrine Society",

number = "8",

}

TY - JOUR

T1 - Response to Letter to the Editor From Chatelain et al

T2 - “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

AU - Miller, Bradley S.

AU - Blair, Joanne C.

AU - Rasmussen, Michael Højby

AU - Maniatis, Aristides

AU - Kildemoes, Rasmus Juul

AU - Mori, Jun

AU - Polak, Michel

AU - Bang, Rikke Beck

AU - Böttcher, Volker

AU - Stagi, Stefano

AU - Horikawa, Reiko

PY - 2023/8/1

Y1 - 2023/8/1

UR - https://www.scopus.com/pages/publications/85164843493

UR - https://www.scopus.com/pages/publications/85164843493#tab=citedBy

U2 - 10.1210/clinem/dgad095

DO - 10.1210/clinem/dgad095

M3 - Letter

C2 - 36869702

AN - SCOPUS:85164843493

SN - 0021-972X

VL - 108

SP - e647-e648

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 8

ER -

Response to Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

Publisher link

Find It

Other files and links

Cite this